NFNataly I. Frolova

Nataly I. Frolova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nataly I. Frolova has a total of 86 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Menstrual health and menstrual hygiene of adolescence as factors determining the health of a future woman: a multicentral study

    by Tatiana E. Belokrinitskaya, Белокриницкая Татьяна Евгеньевна, Nataly I. Frolova, Фролова Наталия Ивановна, Viktor A. Mudrov, Мудров Виктор Андреевич, Viktoriia O. Vasilyeva, Васильева Виктория Олеговна, Zhanna A. Krasnoyarova, Красноярова Жанна Александровна, et al.

    Background. The reproductive health of adolescents serves as a crucial indicator of the reproductive potential within a population. The menstrual cycle self-monitoring skills and the hygienic practices acquired during puberty significantly influence women's health in later life. Aim. To analyze the characteristics of menstrual health and hygiene among adolescent girls, with a focus on assessing the risks associated with reproductive disorders. Materials and methods. An anonymous, cross-sectional online questionnaire was distributed to 3,668 girls aged 13 to 17 across four regions in the Far Eastern Federal District. Utilizing cluster analysis, the participants were categorized into low (n=2,104) and high (n=1,564) reproductive risk groups. Statistical analyses were performed using IBM SPSS Statistics 25.0. Results. The age of participants in both groups was statistically comparable (p=0.87). Within the low-risk group, there was a significantly higher prevalence of city residents (64.2% vs. 49.8%; p0.001), individuals with regular menstrual cycles (94.3% vs. 41.2%; p0.001), those maintaining a menstrual calendar (87.4% vs. 52.3%, χ2=312.5; p0.001), and adequate frequency of hygiene practices (95.8% vs. 81.5%; p0.001). Additionally, the age of menarche was notably higher in this group, recorded at 12.0 years (interquartile range: 11.0; 13.0) vs. 11.0 years (interquartile range: 10.0; 12.0) in the high-risk group (p0.001). Pain intensity was lower in the low-risk group, with a score of 2.0 (interquartile range: 1.0; 3.0), compared with 8.0 (interquartile range: 7.0; 9.0) in the high-risk group (p0.001). Key predictors for high risk included dysmenorrhea (odds ratio [OR] 4.2, 95% confidence interval [CI] 3.5–5.1; p=0.001), irregular menstrual cycles (OR 3.8, 95% CI 3.2–4.6; p=0.002), lack of menstrual cycle monitoring (OR 2.1, 95% CI 1.8–2.5; p=0.015), non-compliance with hygiene practices (OR 1.9, 95% CI 1.6–2.3; p=0.032), and residing in rural areas (OR 1.4, 95% CI 1.1–1.7; p=0.041). The regression model created, which incorporates these predictors, demonstrates high discriminatory ability, with an area under the curve of 0.86, sensitivity of 78.4%, and specificity of 81.2%. Conclusion. The assessment of demographic potential indicates that 42.6% of adolescent girls are at a high risk for reproductive disorders. Effective strategies to address this issue may include educational initiatives and awareness campaigns, particularly through online modules that increase access to reproductive education for young women in rural areas. The developed regression model holds potential as a valuable screening tool to enhance the accuracy of individual reproductive prognoses.

  • Assessment of the significance of menstrual cycle and hygiene parameters in adolescents to determine the risk of reproductive disorders

    by T.E. Belokrinitskaya, N.I. Frolova, V.A. Mudrov, V.O. Vasilyeva, Zh.A. Krasnoyarova, A.A. Ochirova, V.M. Aslanova, A.A. Zherlova, K.A. Uskova, Yu.A. Rupisova

  • Open Access

    Medical and social characteristics of youth from the perspective of assessing reproductive potential: a multicentral study in the Far Eastern Federal District. A cross-sectional one-step study

    by Tatiana E. Belokrinitskaya, Nataly I. Frolova, Viktor A. Mudrov, Irina V. Zhukоvets, Rosa D. Philippova, Marina P. Rinchindorzhieva, Tuiana B. Zhamyanova, Natalia A. Vayrakh, Anastasiia S. Dyachkovskaya, Anna K. Kolodezhnaya

    Introduction. In the context of the demographic crisis in modern Russia, the focus of the state’s demographic policy is aimed at young people. The reproductive health (RH) and positive reproductive attitudes (RA) of young people, whose number is progressively declining, are especially important for ensuring population reproduction. Aim. To assess the RH and RA of the student-age population from the standpoint of demographic potential. Materials and methods. A cross-sectional study was conducted based on an anonymous online interview of young people using a specially created questionnaire. The statistical database was developed based on 2005 questionnaires completed by I–VI-year students and residents of medical universities of four subjects of the Far Eastern Federal District: Amur State Medical Academy (Amur Region), Chita State Medical Academy (Trans-Baikal Territory), Banzarov Buryat State University (Republic of Buryatia), Ammosov North-Eastern Federal University (Republic of Sakha, Yakutia). Mathematical analysis of the results was performed using the IBM SPSS Statistics version 25.0 software. Differences were considered significant at p 0.05. Results. 11.4% of female and 1.1% of male respondents had chronic diseases of the reproductive system. Reproductive diseases accounted for 82.8% of gynecological pathology: 54.2% of polycystic ovary syndrome, 11.3% of pelvic inflammatory disease, 8.9% of external endometriosis, 5.4% of menstrual disorders, 3% of female infertility [pχ2 0.001, odds ratio 22.97 (95% confidence interval 13.05–40.46)]. In 32.7% of respondents, sexual debut occurred before the age of 18. The majority of respondents (67.8%) do not consider early onset of sexual activity to be a risk factor for RH (pχ2 0.001), and 68.2% received information about the contraception method for the first time in their lives from unreliable sources of information (friends/relatives, Internet resources), and only 31.8% from healthcare professionals. Contraceptive methods currently used include condoms (88.2%), oral contraceptives (20.5%), withdrawal (18.8%), rhythm method (8.6%), and intrauterine contraceptives (1.2%). 5.8% of respondents have children, 94.2% are childless, of which 6% are childfree. In the future, 94% of respondents plan to have children at 20–24 years (11.8%), 25–29 years (62.7%), 30–34 years (15.7%), 35 years and older (3.8%). Causes of delayed childbearing and voluntary childlessness include getting an education (77.7%; pχ2 = 0.019), fear of financial difficulties (56.8%; pχ2 = 0.619), career priority (47.7%; pχ2 = 0.680), common law marriage (46.8%; pχ2 = 0.103), not sure about the future (33.0%; pχ2 = 0.620), relationship problems within a couple (27.0%; pχ2 0.001), do not want to be responsible (22.4%; pχ2 0.001). In general, 70.5% of respondents consider the state policy aimed at supporting motherhood to be effective; 29.5% do not or rather do not consider it effective (pχ2 0.001). The majority of respondents considered the improvement of housing conditions to be the most effective measure for deciding on the birth of a child in a young family [66.2%; pχ2 0.001, odds ratio 1.29 (95% confidence interval 1.13–1.48)]. The desired number of children was 2.05 ± 0.9 [0; 4], and in case of adequate living, material, and financial conditions available, it was 2.37 ± 1.0 [0; 4] (p 0.05). Conclusion. The state of RH and RA in modern youth can have a negative impact on the quality of the demographic potential of the population. Active cross-departmental work with young people on education in the field of RH and the fostering of commitment to its protection, education of family-oriented values, and positive RA is necessary.

  • Open Access

    Abdominal pregnancy: two cases of critical obstetric conditions with different perinatal outcomes. Case report

    by Tatiana E. Belokrinitskaya, Nataly I. Frolova, Anna A. Kustova, Ekaterina Y. Nikolaeva, Anastasiya O. Zolotukhina, Tatiana M. Barkan, Natalia N. Byshina, Белокриницкая Татьяна Евгеньевна

    Abdominal pregnancy (AP) is rare and is associated with high rates of maternal and perinatal mortality compared to other ectopic pregnancies (EP). Despite using advanced imaging techniques in prenatal diagnosis, diagnosing and treating AP remain challenging. Progressive advanced AP may remain undiagnosed for a long time due to the absence of specific clinical symptoms, errors in the interpretation of echographic patterns by radiologists, and a lack of alertness due to the rarity of this type of EP. This article describes two authors' observations of AP that resulted in critical obstetric conditions due to massive blood loss. The first case of AP in a pluripara patient concluded at week 34 with live birth and hysterectomy for placenta ingrowth (PAS2). In the second case, the AP was terminated early. In both patients, the trophoblast was implanted on the uterus; there were no known risk factors for EP, and the diagnosis of AP was established intraoperatively. According to modern Russian and foreign literature, in most cases, EP is diagnosed intraoperatively due to the lack of a standard algorithm for diagnosis and treatment. Standardization of treatment guidelines for AP trimesters II and III, perioperative treatment options, and postoperative management, based on a summary of all cases reported worldwide, could reduce the risk of maternal and fetal complications and mortality.

  • Open Access

    Reproductive intentions, knowledge, and reproductive health of university students: a multicentral study in the Far Eastern Federal District

    by T.E. Belokrinitskaya, N.I. Frolova, V.A. Mudrov, I.V. Zhukovets, R.D. Philippova, M.P. Rinchindorzhieva, T.B. Zhamyanova, N.A. Vayrakh, A.S. Dyachkovskaya, A.K. Kolodezhnaya

    Репродуктивные ориентиры, знания и репродуктивное здоровье учащихся вузов: многоцентровое исследование в Дальневосточном федеральном округе

  • Open Access

    The role of cytokines and interferons during pregnancy

    by T. Е. Belokrinitskaya, Yu. A. Vitkovsky, N. I. Frolova, Ю. А. Витковский

    Immune cells, cytokines, and interferons are key mediators that ensure the gestational process from implantation to childbirth. The coordination of their signaling pathways determines molecular interactions between the mother and the fetus, the physiological course of pregnancy and its outcomes, particularly in the context of maternal respiratory viral infections. Here we analyze current information on physiological and pathological roles of cytokines and interferons during gestation in both uncomplicated and complicated pregnancies. Disrupted cytokine signaling might significantly alter fetal and placental development, leading to pregnancy complications and birth defects.


  • Open Access

    POST-COVID-19-syndrome in young healthy women: myth or reality?

    by Tatiana E. Belokrinitskaya, Nataly I. Frolova, Viktor A. Mudrov, Kristina A. Kargina, Evgeniya A. Shametova, Chimita Tch. Zhamyanova, Shakhnozakhon R. Osmonova, Белокриницкая Татьяна Евгеньевна

    Aim. To assess the incidence and severity of new persistent symptoms in somatically healthy young women with and without a history of COVID-19. Materials and methods. The main study group included patients who had PCR-confirmed COVID-19 in JulyOctober 2021 (n=181); the comparison group included women without COVID-19 during this period (n=71). Inclusion criteria: female sex, age 1835 years, no pregnancy, overweight/obesity, diabetes mellitus, chronic hypertension, premenstrual syndrome, and other somatic and/or chronic infectious diseases. Post-COVID syndrome (PCS) was diagnosed based on symptoms absent before COVID-19, appeared 4 weeks from the disease onset, and lasted at least 2 months, which could not be explained by alternative diagnoses. We used primary medical records and interviewed patients using a special questionnaire to develop a statistical database. The severity of symptoms was assessed using a 10-point scale. Results. New persistent symptoms during the pandemic in young, initially somatically healthy women with and without COVID-19 were reported with similar frequency: 96.1 and 93.0%, respectively (odds ratio OR 1.88, 95% confidence interval CI 0.586.14; p2=0.327). Only patients with COVID-19 reported cough (43.6%), shortness of breath (26.5%), chest pain (18.2%), weight loss (18.8%), hair loss (60.8%); in the comparison group, these symptoms were not reported; p20.001. Patients with PCS were more likely to experience memory impairment 49.2% vs 12.7% (OR 6.66, 95% CI 3.1314.21; p20.001); headache 43.1% vs 11.3% (OR 5.96, 95% CI 2.713.17; p20.001); depression 19.9% vs 8.5% (OR 2.69, 95% CI 1.086.7; p2=0.029); myalgia 31.5% vs 8.5% (OR 4.98, 95% CI 2.0412.17; p20.001). Patients of both groups showed similar frequency of fatigue (69.0% vs 71.8%; p2=0.66), drowsiness (54.9% vs 43.6%; p2=0.11), palpitations (19.7% vs 29.8%; p2=0.1), menstrual cycle changes (22.5% vs 21.0%; p2=0.865), and skin manifestations (2.8% vs 6.6%; p2=0.24). COVID-19 survivors had a more pronounced memory impairment (4.0 vs 1.0 points; p0.001), headache (5.0 vs 3.0 points; p=0.001), myalgia (5.0 vs 1.0 points; p0.001) and less severe insomnia (3.0 vs 5.0 points; p=0.004). Conclusion. The PCS symptoms are common in initially somatically healthy women of early reproductive age. Similar symptoms in women with no history of COVID-19 may be due to post-traumatic stress anxiety disorder. Further interdisciplinary research is needed to identify the pathophysiological mechanisms for the occurrence of new persistent symptoms in different age and social groups during the COVID-19 pandemic.


  • Open Access

    Clinical characteristics and confounders of the new coronavirus infection in low-risk pregnant women: an analysis of three years of the pandemic: A cross sectional study

    by Tatiana E. Belokrinitskaya, Nataly I. Frolova, Kristina A. Kargina, Evgeniya A. Shametova, Mariya I. Chuprova, Kristina A. Rodionova, Белокриницкая Татьяна Евгеньевна

    Background. During the three years of the new coronavirus infection (NCI) pandemic, young women of low infectious risk made a certain contribution to the severe maternal morbidity and mortality from COVID-19. Aim. To establish risk factors for morbidity and give a clinical assessment of COVID-19 during epidemic outbreaks in 2020, 2021, and 2022 in low-risk pregnant women. Materials and methods. The study included three groups of pregnant women with clinically manifested and laboratory-confirmed SARS-CoV-2 infection: 163 pregnant women who became ill in the first wave of the epidemic in October-December 2020, 158 in the second and third epidemic wave in July and October 2021, and 160 in the fourth epidemic wave in JanuaryFebruary 2022. Each comparison group included 100 pregnant women who did not become ill during the same periods of the pandemic. Patients of all groups were in the III trimester of gestation, comparable in age (1835 years), social status, parity, and body mass index, and had no known risk factors for COVID-19. Results. Iron-deficiency anemia, tobacco smoking, and belonging to the East Asian ethnic group showed a stable association with the incidence of COVID-19 in low-risk pregnant women. In the first year of the pandemic (strains zero and Alpha), the clinical presentation of NCI was dominated by a loss of smell and/or taste (87.7%), drowsiness (68.7%), and dyspnea even with a mild degree of lung damage (68.1%). The epidemics of the second year of the COVID-19 pandemic (Delta strain) were characterized by a more severe course of the disease than in the first year: fever was more often reported above 38C (19.6% vs 7.4%; p2=0.006), pneumonia confirmed by computed tomography (61.4% vs 21.4%; p20.001), severe lung damage (CT-3: 11.4% vs 4.9%; p2=0.040; CT-4: 0 vs 6.3%; p20.05), intensive care unit admission (11.4% vs 6.4%; p2=0.041); there were cases of invasive mechanical ventilation (1.89% vs 0; p2=0.118) and deaths (0.63% vs 0; p2=0.492). In the epidemic of the third year of the pandemic (Omicron strain), the COVID-19 clinical presentation was similar to seasonal acute respiratory viral infection: the predominant symptoms included runny nose (66.7%) and cough (54.4%); pneumonia was rare (3.8%). Conclusion. Iron deficiency anemia, tobacco smoking, and belonging to the East Asian ethnic group are confounders of COVID-19 disease in pregnant women without known infectious risk factors. Unlike the epidemics of the first and third year of the pandemic with dominant zero, Alpha, and Omicron strains, epidemic outbreaks of the second year of COVID-19 caused by the Delta strain were characterized by the most severe disease course, a high rate of pneumonia and deaths even in low-risk patients.


  • Open Access

    COVID-19 pandemic in low-risk pregnant women in 2020-2022: disease confounders and clinical characteristics

    by T. E. Belokrinitskaya, N. I. Frolova, K. A. Kargina, E. A. Shametova, M. I. Chuprova, K. A. Rodionova

    Aim. To identify confounders and clinical symptoms of COVID-19 in low-risk pregnant women during the pandemics from 2020 to 2022.Materials and Methods. The study included pregnant women with COVID-19: 1) those who have been admitted in October-December 2020 (n = 163); 2) those who have been admitted in May-August 2021 (n = 158); 3) those who have been admitted in January-February 2022 (n = 160). Patients in all groups were in the 3st trimester of gestation and were comparable in age (18–35 years), socioeconomic status, parity, body mass index, and had no established risk factors for COVID-19.Results. Iron deficiency anemia, tobacco smoking, and belonging to the East Asian ethnic group were recognized as reliable confounders for COVID-19 in pregnant women. In the 1st year of the pandemic, the most common symptoms were: loss of smell/taste (87.7%), somnolence (68,7%), and shortness of breath (68.1%). In the 2nd pandemic year, SARS-CoV-2 Delta variant more frequently resulted in fever above 38°C (19.6% vs 7.4%), pneumonia (61.4% vs 21.4%), respiratory failure (17.7% vs 4.9%), admission to intensive care unit (11.4% vs 6.4%), and invasive mechanical ventilation (1.89% vs 0). Symptoms of COVID-19 in the 3rd year of the pandemic were similar to those observed in seasonal acute respiratory viral infections: runny nose (66.7%) and cough (54.4%), whereas the cases of pneumonia were rare (3.8%).Conclusion. Among the most reliable confounders of COVID-19 in pregnant women without any risk factors in the 3rd trimester of gestation are iron deficiency anemia, tobacco smoking, and belonging to the East Asian ethnic group. Each SARS-CoV-2 variant provoked vastly different symptoms.

  • Assessment of the effectiveness of COVID-19 preventive measures in pregnant women

    by T.E. Belokrinitskaya, Chita Chita State Medical Academy, N.I. Frolova, K.A. Kolmakova, E.A. Shametova, I.Yu. Veselkova, Sh.R. Osmonova, Chita City Clinical Hospital No 1, Chita Central District Hospital

    Objective. To assess the effectiveness of different preventive measures for novel coronavirus infection in pregnant women. Patients and Methods. This study included 125 pregnant women hospitalized with moderate to severe laboratory-confirmed SARS-CoV-2 infection between September and November 2021 (the fourth pandemic wave), and 175 pregnant women who were not infected with COVID-19 during the same period. All women in these two groups were comparable for gestational age (II–III trimesters, 24–39 weeks), age (20–40 years), social status, parity, body mass index, and had no known COVID-19 risk factors. Results. Our findings revealed that vaccination 3-5 months before pregnancy (OR = 4.12; 95% CI 1.28–13.27; χ2 = 0.022), inconsistent use and/or non-timely replacement of face masks (OR = 5.71; 95% CI 2.83–11.51) were associated with the increased risk of COVID-19 in the second and third trimesters of gestation. It was showed that systematic (once in the morning at 24–48-hour intervals) intranasal administration of recombinant interferon alpha-2b (IFN-α; Grippferon) as compared with a single application after exposure to COVID-19 reduced the disease incidence rate and there was no evident risk of illness (OR = 0.08; 95% CI 0.05–0.14; 19.2% vs 74,3%, p < 0.001). This can be explained by the fact that women were mostly infected in unpredictable conditions (e.g., 29.2% of pregnant women were infected from family members, 23.9% had unknown source of exposure). The use of umifenovir, not currently authorised for the medication-assisted prevention of COVID-19 in pregnant women, and rectal administration of IFN-α suppositories did not reduce the disease incidence rate. Rectal use of IFN-α suppositories by pregnant women off-label increased the incidence (32.0 vs 15.4%, p = 0.001) and risk of developing novel coronavirus infection (OR = 2.58; 95% CI 1.48–4.50). Conclusion. There is a need to improve awareness among pregnant women about the mandatory and timely vaccination against COVID-19 during pregnancy and the importance of strict adherence to wearing face masks. Increased efforts should be made to monitor and inform pregnant women about the use of only authorised medication-assisted preventive measures of SARS-CoV-2 infection, such as intranasal administration of recombinant IFN α-2b (Grippferon). During the epidemic rise in COVID-19 cases, the systematic intranasal administration of recombinant interferon-based medication Grippferon (once in the morning at 24–48-hour intervals) is recommended for pregnant women. Key words: pregnancy, COVID-19, incidence rate, vaccination, recombinant interferon alpha-2b, Grippferon, prevention